Logo Image
News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAI Pulse CheckAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions PodcastShorts
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers
Event Calendar

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Event Calendar
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

Peter Yehl

Advertisement

Articles by Peter Yehl

Early Development GMPs for Small-Molecule Specifications: An Industry Perspective (Part V)

ByDennis O'Connor,James S. McElvain,Mark D. Trone,Michael Coutant,Michael Szulc,Mehran Yazdanian,Shuhong Zhang,Scott A. Miller,Peter Yehl,Kirby Wong-Moon,Zhihong Ge,Frank Swanek
October 2nd 2012

IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development.

Advertisement

Latest Updated Articles

  • Early Development GMPs for Small-Molecule Specifications: An Industry Perspective (Part V)
    Early Development GMPs for Small-Molecule Specifications: An Industry Perspective (Part V)

    October 2nd 2012



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

Can AI Agents Satisfy CGMP Documentation Requirements?

2

Q&A: How Can Sponsors Respond to Clinical Trial Customs Delays?

3

Introducing the "PharmTech AI Pulse Check" Expert Video Series

4

CPHI Milan 2026: Trends in Pharma

5

CPHI Milan 2026: AI and Bioavailability, Part 2

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us